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Abstract
Introduction: The neurobiological mechanisms underlying recovery from or persistence of low back pain (LBP) remain
misunderstood, limiting progress toward effective management. We have developed an innovative two-tier design to study the
transition from acute to chronic LBP. The objective of the first tier is to create a provincial web-based infrastructure to recruit and
monitor the trajectory of individuals with acute LBP. The objective of the second tier is to fuel hypothesis-driven satellite data
collection centers with specialized expertise to study the role of biomechanical, epigenetic, genetic, neuroanatomical, ontological,
physiological, psychological, and socioeconomic factors in LBP chronicity.
Methods: This article describes the first tier of the protocol: establishment of the Core Dataset and Cohort. Adults with acute LBPwill be
recruited through networks, media, and health care settings. A web-based interface will be used to collect self-reported variables at
baseline and at 3, 6, 12, and 24months. Acute LBPwill be defined according to the Dionne 2008 consensus. Measurements will include
the Canadian minimum data set for chronic LBP research, DN4 for neuropathic pain, comorbidities, EQ-5D-5L for quality of life, and
linkage with provincial medico-administrative databases. The primary outcome will be the transition to chronic LBP, as defined by Deyo
2014. Secondary outcomes include health care resource utilization, disability, sick leave, mood, and quality of life.
Perspective: This study brings together diverse research expertise to investigate the transition from acute to chronic LBP,
characterize the progression to recovery or chronicity, and identify patterns associated with that progression.
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1. Introduction
The estimated worldwide 1-month prevalence of low back pain
(LBP) is as high as 23%, suggesting that about a quarter of the
global population experiences LBP in any given month.25,32
According to a recent systematic review, the lifetime prevalence
of LBP ranges from2% in urban adults aged$15 years in Pakistan
to 86% among adults ($18 years) in Germany.25 Low back pain is
also the leading cause of global years-lived-with-disability.44 The
high prevalence of LBP has significant economic consequences,
with direct medical cost estimates ranging from 12.2 to 90 billion
US dollars annually.10 Low back pain is the sixth most costly
disease, behind ischemic heart disease, motor vehicle accidents,
acute respiratory infections, arthropathies, and hypertension.13
Most LBP cases cannot be linked conclusively to a specific
nociceptive source or pathoanatomical cause,31 and factors
associated with LBP chronicity remain poorly understood.2,21,27
Although some risk factors havebeen extensively studied (individual/
socioeconomic, occupational, pain characteristics, and psycholog-
ical),5,18,30,33,34 others have not (biomechanical, epigenetic, genetic,
and neuroanatomical). A better understanding of the vulnerabilities
underlying recovery or persistence of LBP will allow for early
intervention and prevention of the progression to a chronic state.
Many regions or countries are developing acute LBP cohorts
including Australia, United States, and Denmark.9,22,28,35 Although
comprehensive longitudinal data can be derived from these
cohorts, limitations exist. For example, recruitment of participants
from a limited number of clinicians located in a restricted geo-
graphical region excludes individuals who have not seen a pro-
fessional, who have seen a professional not participating in the
cohort study, or who live outside the designated region. A number
of additional large8,16 and smaller14,15 prospective cohorts have
initiated recruitment without a clear focus on any particular stage of
LBP. Finally, other large cohorts have been built to identify the
occupational aswell as the sociodemographic, general health, and
psychological risk factors for the occurrence of chronic LBP
without a clear strategy for the integration of these factors with
biomechanical, epigenetic, genetic, and neuroanatomical charac-
teristics.19,26,39 A unifying project, focused on the transition from
acute to chronic LBP that brings together basic, clinical, and
epidemiological methods/expertise, is needed to understand the
complex nature of these factors and their interactions.
The Quebec Low Back Pain Study (QLBPS), a strategic initiative
of the Quebec Back Pain Consortium (QBPC; https://back-
painconsortium.ca) and the Quebec Pain Research Network
(QPRN; https://qprn.ca/en), was created to address these limi-
tations. The proposed design enables the integration of information
across multiple domains, thus providing a comprehensive view of
risk factors for LBPchronicity. The scientific committee of theQBPC
is composed of experts from diverse disciplines including physical
therapy and biomechanics, epigenetics, genetics, neuroanatomy,
medicine, epidemiology, and health ontology and psychology, in
addition to patients’ perspective representatives. The long-term
goal of our consortium is to establish a province-wide online
database for longitudinal studies of individuals with LBP. This will
provide a comprehensive view of the risk factors for the
development of chronic LBP that will break disciplinary silos.
2. Methods
This multidisciplinary, longitudinal cohort protocol has been
prepared according to the SPIRIT 2013 guidelines for complete-
ness and quality of trial protocols7 and complies with the
Strengthening the Reporting of Observational Studies in Epide-
miology (STROBE) statement.42,43
2.1. Context
The QLBPS was developed by the QBPC, a strategic initiative of
theQPRN funded by the FondsdeRecherche duQue´bec—Sante´,
a provincial government funding agency. The scientific committee
has been meeting regularly since 2015 to develop a shared vision
and to design and implement the study described here. Figure 1
illustrates the vision and participating institutions.
2.2. Study design
Wewill use a 2-stage approach (Fig. 2). The first stage, described
here, will create the QLBPS Core Dataset and Cohort. Self-
reported variables will be assessed in this provincial sample of
Figure 1. Quebec Back Pain Consortium vision and participating members.
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patients suffering from LBP with follow-ups at 3, 6, 12, and 24
months after baseline. The Cohort will then “fuel” smaller studies
in the second stage where patients will be invited to visit specific
research laboratories for more extensive measurements (eg,
biomechanics, epigenetics, genetics, neuroimaging, and sensory
testing). All data collected from the first stage will be available for
the satellite projects conducted in the second stage.
2.3. Inclusion and exclusion criteria
Potential participants will be 18 years and older, have internet
access, be fluent in either French or English, and have self-
reported LBP. No specific exclusion criteria will be applied.
2.4. Recruitment
Recruitment was initiated in November 2018 and is ongoing; 46
acute LBP patients completed the baseline questionnaires in the
7-month period between November 2018 and June 2019. In
consultation with marketing experts, we then optimized of our
recruitment strategy, resulting in 7 additional acute LBP patients
weekly between June 2019 and August 2019. The recruitment
strategy includes the following target populations: (1) general
population in the province of Quebec (through advertisement in
newspapers, public means of transportation, and social media
such as Facebook); (2) individuals or institutions by email list
servers; (3) populations of individuals at risk of LBP (through
advertisement with patient advocacy organizations or profes-
sional societies [ie, Association que´be´coise de la douleur
chronique, QPRN, Canadian Pain Society]); (4) unions of workers
at risk for LBP (including but not limited to construction workers,
warehouse workers, public service workers [ie, police and
firefighters], nurses, other allied health professionals, and bus
drivers); and (5) medical populations (through advertisements in
emergency units, medical, physiotherapy, chiropractic, radiology
clinics, and pharmacies).
In parallel to the acute-phase recruitment, individuals with
chronic LBP who self-register for the study will be included in the
Core Database. Their longitudinal data will be valuable for
comparative purposes, for additional trajectory analyses, and
for recruitment of chronic LBP participants in affiliated satellite
projects.
2.5. Data collection methods
The recruitment strategies listed above will all include an invitation
to a web platform (https://backpainconsortium.ca/), and/or
aliases mybackhurts.ca or malaudos.ca. On this platform,
interested participants will be asked to provide their postal code,
sex, age, pain location, and intensity. Potential participants will
confirm their interest by providing their email and full name andwill
complete a CAPTCHA (Completely Automated Public Turing Test
To Tell Computers and Humans Apart) verification. Only those
providing all the required information and that self-identify with
LBP will receive an email inviting them to access the baseline
online survey. This email will also include a link to the informed
consent form, will encourage potential participants to read the
document carefully, and will inform them that the study co-
ordinator is available for any questions. Participants will be
enrolled after they electronically provide their consent to
Figure 2. The Quebec Low Back Pain Study methodology. T0 to T4 represent the different data collection time point for all patients enrolled. Everyone will
complete the core minimal data set 5 times within the period of 2 years. The baseline questionnaires will be used to categorize patients into acute or chronic LBP
and identify risk factors that predict the maintenance of the LBP. At 3 months and for all subsequent time points, LBP status will be re-evaluated along with
secondary outcomes.When patients consent, the provincial health plan number (RAMQ, Re´gie de l’assurancemaladie du Que´bec) will be collected tomerge with
their medical and prescription drug claims. Finally, at any point during their active participation in the study, patients could be solicited to participate in one or more
of the ongoing satellite projects. LBP, low back pain.
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participate. They will also be asked whether they are willing to be
contacted again by other researchers and/or if they are willing to
donate a blood sample. Once enrolled, they will be automatically
redirected to the web-based baseline self-administered ques-
tionnaire. Baseline and follow-up questionnaires are hosted on
the data collection platform Research Electronic Data Capture
(REDCap) for electronic collection and management of research
data. Completion of the baseline questionnaire takes approx-
imately 20 minutes to complete. At 3, 6, 12, and 24 months after
completing the baseline questionnaire, participants will receive an
email with a unique link for completion of follow-up web-based
questionnaires that take approximately 20 minutes to complete.
Evidenced-based retention strategies1,20,36 will be applied. At
each time point, participants who do not complete the above-
mentioned questionnaires will be contacted by the study co-
ordinator by phone and/or e-mail no more than 3 times. Other
retention strategies include sending a quarterly newsletter to
recruited participants to inform them of study progress, to share
relevant information and resources about LBP, and to “humanize”
the research by bridging the gap between researchers’ goals and
participants using photographs and biographies, for example.
Participants will have the potential to share their experience with
other participants through the newsletter and will receive tokens of
appreciation as they complete steps in the study such as a pen,
a fridgemagnet, or a badge. Finally, all participants will be invited to
enter into drawings for prepaid VISA cards.
2.6. Study variables and validated measurements
Multiple meetings between the authors and a thorough review of
the existing literature on LBP and psychometric measurements
were conducted to select the core data set. Criteria for inclusion
in the core data set was based on recommendations from expert
research groups, including the National Institutes for Health
Research (NIH) Task Force on Research Standards for Chronic
Low Back Pain11 and the IMMPACT consensus recommenda-
tions.41 Measures included in the core data set are presented in
Table 1. A trick question (please select number 4 in the options
below) has been inserted to gauge the quality of participants’
responses. Permission has been obtained to use the NIH, DN4,
and EQ-5D-5L questionnaires for research purposes. The
complete set of questions is included in Supplementary Appendix
1 (available as supplemental digital content at http://links.lww.
com/PR9/A59). The psychometric properties of the scales are
included in Supplementary Appendix 2 (available as supplemen-
tal digital content at http://links.lww.com/PR9/A59).
2.7. Characterization of low back pain status
The criteria for acute LBP will be based on the consensus
statement of Dionne and colleagues.12 According to their
recommendations, patients who answer “yes” to the 2 following
questions are suffering from acute LBP: (1) In the past 4 weeks,
have you had pain in your lower back (in the area shown on the
diagram), and (2) if yes, was this pain bad enough to limit your
usual activities or change your daily routine for more than
one day?
2.8. Primary outcome
The primary outcome of the Core Dataset is whether participants
who reported acute LBP at baseline will transition to chronic LBP.
Chronic LBP will be defined based on the NIH task force
recommendations that define chronic LBP as an ongoing
problem for at least 3 months and that has resulted in a problem
on at least half of the days in the past 6 months.11
2.9. Secondary outcomes
Secondary outcomes include the duration of the LBP episode
and/or the presence (and number) of recurrent LBP episodes,40
work status, use of health care resources and direct medical
costs incurred (including economic burden data), participants’
functional limitations and sick leave, mood, as well as the
longitudinal trajectory of health-related quality of life.
2.10. Data analysis (Core Dataset)
All study variables will be screened for normality as well as
univariate and multivariate outliers. Missing data will be handled
with multiple imputation when indicated.37 Mean values, medians,
and SDs will be computed for continuous variables while
percentages and frequencies will be computed for categorical
variables. Depending on the distribution of variables, longitudinal
changes in pain severity and their predictorswill be examined using
various multivariate approaches, including latent class analysis or
hierarchical cluster informed by linear regression. A P-value#0.05
will be considered statistically significant.
The QLBPS Core Cohort is a continuous recruitment platform;
thus, nominimumormaximumnumber of participants has been set.
2.11. Ethical approval and confidentiality
The QLBPS Core Dataset (first tier) has received ethical approval
from McGill University (A06-M22-18A) and will be conducted in
conformity with the ethical principles set forth by the Regulatory
Framework in Health Research at the McGill University Health
Centre in accordance with the second edition of the Tri-council
Policy Statement. Participants will be automatically assigned
a study ID by REDCap ensuring that only the principal investigator
and study coordinators will have access to participants’ ID.
Nominal data and study ID numbers are kept in a separate Excel
file protected by a password. All other study investigators and
staff will have access to denominalized data. Any important
protocol modifications will be subject to approval from the
scientific committee of the Quebec Back Pain Consortium and
the Ethics Committee of McGill University.
2.12. Second-stage sampling
In the baseline online survey, participants will be asked whether
they are willing to be contacted for participation in additional
studies, where they live and whether they would consider donating
blood. The answers will be recorded in the Core Database and will
be used to identify participants who may be contacted by other
QPRN-approved investigators for satellite data collection centers. If
participants are interested in donating blood, they will receive an
email from the QLBPS Biobank Team. The biobank is covered
under a separate sister protocol at the McGill Ethics Committee
entitled “Quebec Low Back Pain Biobank” (A08-M23-18A).
2.13. Satellite projects
Researchers with ethical approval at their home institutions and
from the scientific committee of the QLBPS will be provided
participants’ study ID, name, and contact information. This is the
only time that investigators will have access to nominalized data
and will be for recruitment purposes only. All other internal and
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external researchers will have access to the deidentified QLBPS
Core Dataset upon request. A current list of scientific committee-
approved satellite projects is shown in Table 2.
2.14. Assignation and allocation rules for the
satellite projects
Participants who agreed to be contacted to participate in
additional studies will be assigned to ongoing satellite projects
associated with the QLBPS based on each project’s inclusion
and exclusion criteria. As part of the consortium, researchers of
ongoing satellite projects will have a shared script and recruitment
efforts will be coordinated by the consortium study coordinator.
This shared workflow will optimize the utility of the cohort and
minimize burden to patients. Potential bias to the dispatch
process of participants into satellite projects include geographic
location of participants, which may limit the projects they can
enroll in, and participants’ willingness to undergo procedures
such as blood donation or magnetic resonance imaging. Bias in
the assignment to satellite studies that are in competition for
Table 1
Details of measures and variables included in the minimal core data set.
Domain Names of measures Details of measures
Definition of acute LBP Acute LBP classification12 Participants will complete 2 questions required for
the acute LBP definition
LBP—pain and associated psychosocial
characteristics
French- and English-Canadian cross-cultural
adaptation29 of the National Institutes of Health
Research Task Force on Research Standards for
Chronic Low Back Pain11
LBP characteristics (8 questions about LBP
duration, intensity, and sciatica); these data enable
the participants to be classified with chronic LBP
according to the NIH-recommended definition
Items included in this questionnaire were in part
taken from the Patient-Reported Outcomes
Measurement Information System (PROMIS)6 and
from the Keele Start Back Screening Tool24
Comorbid painful conditions (1 question to
document stomach pain, pain in other sites,
headaches, and widespread pain)
History of LBP surgical interventions (3 questions)
Pain interference (4 questions—PROMIS)
LBP treatments (1 question to document opioid use,
infiltrations/injections, exercise therapy, and
psychological counseling)
LBP-related workplace absenteeism and benefits (2
questions)
Physical function (4 questions—PROMIS)
Emotional distress/depression (4
questions—PROMIS)
Sleep disturbance (4 questions—PROMIS)
Kinesiophobia (1 question)
Catastrophizing (1 question)
LBP-related lawsuits and legal claims (1 question)
Substance abuse (2 questions)
Sociodemographic profile (6 questions)
Smoking status (1 question)
Obesity (1 question)
Health care and medication use Quebec medico-administrative databases (Re´gie de
l’Assurance maladie du Que´becMed-ECHO)
Provincial administrative databases and private
medical insurance databases using self-reported
unique provincial health insurance number (data
extraction period: 1 year earlier and 1 year after the
date of cohort entry/baseline questionnaire)
Neuropathic pain DN4 (7-item version)4 This questionnaire (self-report items only) assesses
the neuropathic component of chronic pain.
Health-related quality of life EQ-5D-5L23 Five dimensions of health (mobility, self-care, usual
activities, pain/discomfort, and anxiety/depression)
scored on 5 levels (no, slight, moderate, severe, and
extreme problems/unable to) are used to measure
health-related quality of life
Comorbidities Self-Administered Comorbidity Questionnaire38 For each of 12 medical conditions frequently
encountered in general practice, participants must
report whether they have this condition, and if yes,
whether they are receiving treatment for it and if it
limits their activities
Global Impression of Change (follow-ups only) Global Impression of Change scales [inspired
from17]
Participants rate the extent to which they feel their




In the past 3 months, using a 7-point Likert scale
(no change/almost the same/a little better/
somewhat better/moderately better/better/a great
deal better)
LBP, low back pain.
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subjects will be mitigated by the shared scripts and managed by
the coordinator. More specifically, participants meeting the
criteria for more than one satellite project will be assigned to
projects in turn; priority will alternate between each project, taking
into account the targeted sample size.
2.15. Dissemination
Results from the Core Dataset as well as those from satellite
projects will be presented at national and international confer-
ences and published in peer-reviewed journals in the fields of pain
and musculoskeletal diseases, as well as discipline-specific
journals relevant to the specific questions and methodologies of
the satellite projects.
3. Discussion
A multidisciplinary approach investigating the factors contributing
to the recovery from LBP, the recurrence of LBP episodes, and the
factors influencing the transition to chronic LBPwill be facilitated by
the pragmatic two-stage sampling approach where patients with
acute LBP are continuously enrolled in a core longitudinal cohort
and subsequently recruited for satellite projects tackling specific
questions. Given the high global incidence and costs of
LBP,10,25,32 improved understanding of the mechanisms driving
LBP chronicity is desperately needed.21,27
This study design confers multiple advantages. First, the
existence of the Core Dataset and the composition of its
scientific committee will allow for the examination of the
chronicity of LBP from a large array of research perspectives
including biomechanical, epigenetic, genetic, neuroanatomi-
cal, ontological, psychological, physiological, and socioeco-
nomical mechanisms. This approach will make it possible to
examine simultaneously the multifactorial determinants of LBP
by providing adequate statistical power and measurement.
Second, a common set of carefully selected measures
assessed from the acute phase (baseline) up to 2-year
follow-up will be available to all researchers. These measures
are based on the minimum data set developed by the NIH Task
Force on Research Standards for Chronic Low Back Pain11
and on our Canadian adaptation of those recommendations.29
Third, the Core Dataset will include participants from the entire
province of Quebec, ensuring representation from urban and
rural areas and remote regions. Given its web-based format,
the design also allows for expansion nationally and interna-
tionally. Fourth, for participants who provide their unique
provincial health insurance number, health care use, including
medication, can be studied to assess important aspects of the
economic burden of LBP. Finally, the design provides
a practical solution for deep phenotyping of a subset of
participants while maintaining the sample sizes needed for
epidemiological studies.
Table 2
Satellite projects affiliated with the Quebec Low Back Pain Study.
Principal investigator Affiliated university Study title
Diatchenko, Luda McGill University The Quebec Low Back Pain Biobank (QLBP): a platform for
extended data and biological sample collection, storage, and
distribution of individuals with LBP
Dupuis, Laurent & Hovey, Richard Patient ambassadors & McGill University Patient experience of living with low back pain
Lacasse, Anaı¨s Universite´ du Que´bec en Abitibi-Te´miscamingue Linkage of the QLBPS Cohort with provincial medico-
administrative databases




Universite´ Laval How does thermal therapy work? Mechanisms underlying pain
relief in acute low back pain
Hugo Masse´-Alarie Universite´ Laval How does exercise work? Understanding the mechanisms of
back-muscle exercise on pain processing in different subgroups
of low back pain.
Minerbi, Amir
Shir, Yoram
McGill University Health Centre Composition of the gut microbiome in individuals with chronic
low back pain vs healthy controls as part of the Quebec Low Back
Pain Study;
Dynamics of gut microbiome composition in patients with acute
low back pain. As part of the Quebec Low Back Pain Study
Page´, Gabrielle Universite´ de Montre´al Understanding the mechanisms associated with the transition






An investigation of the effects of physical exercise on the central
nervous system processes underlying the maintenance of
chronic low back pain; effects of aging on cerebral predictors of
pain chronicity
Roy, Jean-Sebastien Universite´ Laval Trunk movement, activity level, and pain perception to predict
chronicity in people with acute low back pain
Stone, Laura McGill University Identification of peripheral biomarkers in chronic pain patients
Wideman, Timothy McGill University Exploring the relationship between sensitivity to physical activity
and rehabilitation outcomes among people with back pain
Integrating international guidelines for pain education within
physiotherapy programs across Canada
LBP, low back pain; NIH, National Institutes for Health Research; QLBPS, Quebec Low Back Pain Study.
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Some limitations must nonetheless be noted. First, no formal
medical validation of participants’ LBP or its potential drivers will
be included for the Core Dataset as all measures will be self-
reported. However, medical validation will be possible in satellite
projects. Second, there will be geographical barriers to partici-
pation in satellite projects such as the physical distance from
research laboratories with specialized equipment or expertise
(eg,MRI facilities specialized in brain and spinal imaging). Third, to
keep the questionnaire short, not all domains are fully explored.
For example, although the NIH section includes several questions
on employment and legal status, job satisfaction is not assessed.
Finally, the Core Dataset is available online through a web-based
platform; participation may therefore be difficult for individuals
with limited computer skills. This concern is mitigated by (1)
availability of our staff to guide participants by phone and (2) data
showing that 88% of individuals in Canada have access to
Internet for personal use.3
Ultimately, the Core Dataset will provide: (1) a pool of potential
LBP patients for other research studies, (2) a database allowing
for investigation s into acute to chronic LBP, and (3) analysis of the
relationships between parameters collected as part of the Core
and affiliated studies, such as pain trajectories and blood-based
genetic or epigenetic factors.
In summary, the QLBPS Core Cohort and Dataset, with its
innovative two-stage sampling approach, will constitute a valuable
platform for the continuousenrolment of LBPpatients to facilitate the
integrated investigation of factors (eg, biomechanical, epigenetic,
genetic, neuroanatomical, ontological, physiological, psychological,
and socioeconomic) contributing to the transition from acute to
chronic LBP, how these factors might change with time as pain
progresses, and what are the health care utilization and medication
patterns associated with that progression. The integration of data
gathered from the QLBPS Core Dataset, and the satellite data
collection centers of expertise will support the development of
comprehensive profiles of patients at risk of LBP chronicity.
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